Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Publication Date timeline is not available.
Page 1
Loss of progesterone receptor may lead to an invasive phenotype in human endometrial cancer.
Eur J Cancer. 2002 Nov;38 Suppl 6:S71-2. doi: 10.1016/s0959-8049(02)00294-0.
Eur J Cancer. 2002.
PMID: 12409083
No abstract available.
Progestogenic effects of tibolone on human endometrial cancer cells.
Blok LJ, De Ruiter PE, Kühne EC, Hanekamp EE, Grootegoed JA, Smid-Koopman E, Gielen SC, De Gooyer ME, Kloosterboer HJ, Burger CW.
Blok LJ, et al. Among authors: kuhne ec.
J Clin Endocrinol Metab. 2003 May;88(5):2327-34. doi: 10.1210/jc.2002-021737.
J Clin Endocrinol Metab. 2003.
PMID: 12727992
Item in Clipboard
The hormone replacement therapy drug tibolone acts very similar to medroxyprogesterone acetate in an estrogen-and progesterone-responsive endometrial cancer cell line.
Hanifi-Moghaddam P, Sijmons B, Ott MC, van Ijcken WF, Nowzari D, Kuhne EC, van der Spek P, Kloosterboer HJ, Burger CW, Blok LJ.
Hanifi-Moghaddam P, et al. Among authors: kuhne ec.
J Mol Endocrinol. 2006 Dec;37(3):405-13. doi: 10.1677/jme.1.02057.
J Mol Endocrinol. 2006.
PMID: 17170081
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.